Intrinsic Value of S&P & Nasdaq Contact Us

Zosano Pharma Corporation ZSAN NASDAQ

NASDAQ Capital Marke • Healthcare • Biotechnology • US • USD

SharesGrow Score
35/100
2/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Stock Statistics — ZSAN

Zosano Pharma Corporation (ZSAN) and trades at $0.56. The 52-week range is 0.46-0.635.

Key metrics include a trailing Price-to-Earnings (P/E) ratio of -2.1, Earnings Per Share (EPS) of $-0.27, annual revenue of $785K.

The stock has a beta of 3.29, operates in the Healthcare sector.

Trading Data
Current Price$0.56
52-Week Range0.46-0.635
Volume1.16M
Avg Volume (30D)5.36M
Beta (1Y)3.29
Company
IPO Date2015-01-27
Employees40
CEOSteven Lo
CountryUS
ExchangeNASDAQ Capital Marke
CurrencyUSD
ISINUS98979H3012
CUSIP98979H301
Income (Latest Year)
Revenue$785K
Gross Profit$-11K
EBITDA$-27.99M
Operating Income$-29.74M
Net Income$-30.11M
EPS$-0.27
EPS Diluted$-0.27
Shares Outstanding$112.06M
Balance Sheet (Latest Year)
Total Assets$48.39M
Current Assets$11.61M
Cash & ST Investments$11.04M
Total Liabilities$15.42M
Total Debt$9.48M
Net Debt$-1.56M
Total Equity$32.98M
Debt / Equity0.29
Valuation Ratios
P/E Ratio-2.1
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message